Back to top
more

Quest Diagnostics (DGX)

(Delayed Data from NYSE)

$155.29 USD

155.29
1,094,683

+0.46 (0.30%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $155.34 +0.05 (0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 12% (29 out of 250)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

Is Quest Diagnostics (DGX) Outperforming Other Medical Stocks This Year?

Is (DGX) Outperforming Other Medical Stocks This Year?

IDEXX Gains on Diagnostics Revenues, New Coronavirus Tests

IDEXX's (IDXX) human health business, OPTI Medical Systems' newly-developed PCR laboratory test kit named OPTI SARS-CoV-2 RNA RT-PCR gains market acceptance.

Boston Scientific's (BSX) ICM System Receives FDA Approval

Boston Scientific's (BSX) new ICM System gets the FDA's nod, thus paving way for better detection and treatment of arrhythmias.

Here's Why You Should Retain DaVita in Your Portfolio Now

Investor confidence is high on DaVita (DVA), thanks to solid prospects.

Myriad Genetics Unveils New Home DNA Sample Collection Kit

Myriad Genetics' (MYGN) home DNA sample collection test kit for its GeneSight Psychotropic test enables physicians to remotely provide treatment options to patients with mental health issues.

QIAGEN's (QGEN) Selloff Deal With Thermo Fisher Progresses

QIAGEN's (QGEN) acquisition deal with Thermo Fisher receives approval from QIAGEN shareholders.

NextGen Virtual Visits Offers Remote Eye Care Facilities

The offering will expand NextGen's (NXGN) ophthalmology services during the coronavirus crisis.

Masimo's New Solution to Reduce Opioid Withdrawal Symptoms

Masimo's (MASI) new solution can help reduce symptoms associated with opioid withdrawal, thereby helping OUD patients with their treatment.

Abbott, Tandem Diabetes Seal Deal on Diabetes Management

Abbott's (ABT) FreeStyle Libre CGM technology to be integrated with Tandem Diabetes' insulin pumps to enhance diabetes care.

LabCorp's Xcellerate Coronavirus Solution to Aid Clinical R&D

This solution by LabCorp (LH) takes the idea from Covance's COVID-19 Operational Recovery Team to better understand the necessities.

Bio-Rad Rides on PCR Test Kits for Coronavirus Amid Cost Woe

The uptick in Bio-Rad's (BIO) core PCR and Droplet Digital PCR product revenues is the result of robust demand due to coronavirus testing and related research.

Here's Why You Should Retain Allscripts (MDRX) Stock for Now

Allscripts (MDRX) continues to benefit from lucrative deals and strong prospects in Sunrise EHR. However, margin contraction remains a woe.

Luminex Expands COVID-19 Testing With New Antibody Test

Luminex (LMNX) submits an EUA request to the FDA for its first multi-antigen IgG assay.

LHC Group Inks Deal With Orlando Health to Improve HCBS

This deal is expected to boost LHC Group's (LHCG) home and community-based business segment.

Myriad Genetics' myPath Melanoma Proved Superior Per New Study

Myriad Genetics' (MYGN) myPath Melanoma's accuracy to classify skin lesions, termed as indeterminate by standard pathological review, validated by the latest study.

Here's Why You Should Hold on to Illumina Stock for Now

Investors continue to be optimistic about Illumina (ILMN) backed by its focus on partnerships and robust demand for its products.

Here's Why You Should Hold on to CONMED (CNMD) Stock for Now

CONMED (CNMD) continues to benefit from robust international sales, broad product portfolio and persistent focus on R&D. However, forex remains a woe.

Masimo's (MASI) New Offering to Improve Patient Outcomes

Masimo's (MASI) Centroid gets FDA clearance and can help clinicians monitor patient position, thereby improving patient outcomes.

Ecolab's Unit Unveils Test Kit for Cooling Water Management

Ecolab's (ECL) bacteria test kit drastically simplifies water-chemistry testing and compliance for cooling water health.

LabCorp Neutralizing Antibody Test to Aid Coronavirus Vaccine R&D

The information related to neutralizing antibody test of LabCorp (LH) can also be used for the screening of convalescent plasma for prophylactic and therapeutic use.

Medtronic's DBS System With BrainSense Technology Gets FDA Nod

Medtronic's (MDT) first-of-its-kind Percept PC DBS system with the next-generation BrainSense technology clears FDA hurdle, paving the way for data-driven neurostimulation treatment.

Here's Why You Should Hold on to ResMed (RMD) Stock for Now

Investors continue to be upbeat about ResMed (RMD) owing to its strong emphasis on product development and consistent high demand for its critical care products.

Ooma, Chico's, Ericsson, Quest and Kroger as Zacks Bull and Bear of the Day

Ooma, Chico???s, Ericsson, Quest and Kroger as Zacks Bull and Bear of the Day

Tandem Diabetes' Sugarmate Buyout Boosts Digital Offerings

Tandem Diabetes (TNDM) expands digital portfolio with the Sugarmate app buyout, paving the way for the company's expansion of diabetes-related products and services ecosystem.

CVS Health Offers Coronavirus Testing for Students, Businesses

CVS Health (CVS) is increasing access to COVID-19 testing options as mass unlocking takes place throughout the nation.